Structure-Based Design, Synthesis, and Antifungal Activity of New Triazole Derivatives

Chemical Biology and Drug Design

Volumn 78, Issue 2, 2011, Pages 309-313

  Sheng, Chunquan ^a   Che, Xiaoying ^a   Wang, Wenya ^a   Wang, Shengzheng ^a   Cao, Yongbing ^a   Yao, Jianzhong ^a   Miao, Zhenyuan ^a   Zhang, Wannian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antifungal activity; CYP51; Phenylacetamide side chain; Rational design; Triazole

Indexed keywords

ACETANILIDE; FLUCONAZOLE; STEROL 14ALPHA DEMETHYLASE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CHEMICAL BINDING; CRYPTOCOCCUS NEOFORMANS; DRUG DESIGN; DRUG SYNTHESIS; HYDROPHOBICITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL;

ACETANILIDES; ANTIFUNGAL AGENTS; AZOLES; DRUG DESIGN; FUNGI; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS;

EID: 79960361444     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2011.01138.x     Document Type: Article

References (26)

1. Fridkin S.K., Jarvis W.R. (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev;9:499-511.
2. Sheehan D.J., Hitchcock C.A., Sibley C.M. (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev;12:40-79.
3. Gallis H.A., Drew R.H., Pickard W.W. (1990) Amphotericin B: 30years of clinical experience. Rev Infect Dis;12:308-329.
4. Denning D.W. (2002) Echinocandins: a new class of antifungal. J Antimicrob Chemother;49:889-891.
5. Ji H., Zhang W., Zhou Y., Zhang M., Zhu J., Song Y., Lu J., Zhu J. et al. (2000) A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. J Med Chem;43:2493-2505.
6. Sheng C., Zhang W., Zhang M., Song Y., Ji H., Zhu J., Yao J., Yu J., Yang S., Zhou Y., Zhu J., Lu J. (2004) Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions. J Biomol Struct Dyn;22:91-99.
7. Sheng C., Miao Z., Ji H., Yao J., Wang W., Che X., Dong G., Lü J., Guo W., Zhang W. (2009) Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother;53:3487-3495.
8. Sheng C., Zhang W., Ji H., Zhang M., Song Y., Xu H., Zhu J., Miao Z., Jiang Q., Yao J., Zhou Y., Zhu J., Lu J. (2006) Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. J Med Chem;49:2512-2525.
9. Chen S.H., Sheng C.Q., Xu X.H., Jiang Y.Y., Zhang W.N., He C. (2007) Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Biol Pharm Bull;30:1246-1253.
10. Casalinuovo I.A., Di Francesco P., Garaci E. (2004) Fluconazole resistance in Candida albicans: a review of mechanisms. Eur Rev Med Pharmacol Sci;8:69-77.
11. Hoffman H.L., Ernst E.J., Klepser M.E. (2000) Novel triazole antifungal agents. Expert Opin Investig Drugs;9:593-605.
12. Aher N.G., Pore V.S., Mishra N.N., Kumar A., Shukla P.K., Sharma A., Bhat M.K. (2009) Synthesis and antifungal activity of 1, 2, 3-triazole containing fluconazole analogues. Bioorg Med Chem Lett;19:759-763.
13. Ezabadi I.R., Camoutsis C., Zoumpoulakis P., Geronikaki A., Sokovic M., Glamocilija J., Ciric A. (2008) Sulfonamide-1, 2, 4-triazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg Med Chem;16:1150-1161.
14. Kagoshima Y., Mori M., Suzuki E., Shibayama T., Iida T., Kamai Y., Konosu T. (2009) Synthesis, cleavage, and antifungal activity of a number of novel, water-soluble ester prodrugs of antifungal triazole CS-758. Bioorg Med Chem Lett;19:3559-3563.
15. Rezaei Z., Khabnadideh S., Pakshir K., Hossaini Z., Amiri F., Assadpour E. (2009) Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives. Eur J Med Chem;44:3064-3067.
16. Uchida T., Kagoshima Y., Konosu T. (2009) Amide analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities. Bioorg Med Chem Lett;19:2013-2017.
17. Uchida T., Somada A., Kagoshima Y., Konosu T., Oida S. (2008) Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in vitro activities. Bioorg Med Chem Lett;18:6538-6541.
18. Arikan S., Rex J.H. (2002) Ravuconazole Eisai/Bristol-Myers Squibb. Curr Opin Investig Drugs;3:555-561.
19. Capilla J., Yustes C., Mayayo E., Fernandez B., Ortoneda M., Pastor F.J., Guarro J. (2003) Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother;47:1948-1951.
20. Che X., Sheng C., Wang W., Cao Y., Xu Y., Ji H., Dong G., Miao Z., Yao J., Zhang W. (2009) New azoles with potent antifungal activity: design, synthesis and molecular docking. Eur J Med Chem;44:4218-4226.
21. Wang W., Sheng C., Che X., Ji H., Cao Y., Miao Z., Yao J., Zhang W. (2009) Discovery of highly potent novel antifungal azoles by structure-based rational design. Bioorg Med Chem Lett;19:5965-5969.
22. Wang W., Sheng C., Che X., Ji H., Miao Z., Yao J., Zhang W. (2009) Design, Synthesis, and Antifungal Activity of Novel Conformationally Restricted Triazole Derivatives. Arch Pharm (Weinheim);342:732-739.
23. Xu Y., Sheng C., Wang W., Che X., Cao Y., Dong G., Wang S., Ji H., Miao Z., Yao J., Zhang W. (2010) Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives. Bioorg Med Chem Lett;20:2942-2945.
24. Ji H., Zhang W., Zhang M., Kudo M., Aoyama Y., Yoshida Y., Sheng C., Song Y., Yang S., Zhou Y., Lu J., Zhu J. (2003) Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. J Med Chem;46:474-485.
25. Giraud F., Guillon R., Loge C., Pagniez F., Picot C., Le Borgne M., Le Pape P. (2009) Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1, 2, 4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorg Med Chem Lett;19:301-304.
26. Lebouvier N., Pagniez F., Duflos M., Le Pape P., Na Y.M., Le Baut G., Le Borgne M. (2007) Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety. Bioorg Med Chem Lett;17:3686-3689.